Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
150.33
-2.01 (-1.32%)
At close: Sep 4, 2026, 4:00 PM EDT
152.00
+1.67 (1.11%)
After-hours: Sep 4, 2026, 7:58 PM EDT
Merck & Co. Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Merck & Co. stock has a consensus rating of "Buy" and an average price target of $148.73. The average 1-year stock price forecast is 1.06% lower than the current stock price, while the lowest is $105 (-30.15%) and the highest is $186 (+23.73%).
Price Target: $148.73 (-1.06%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Merck & Co. stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 15 | 15 | 15 | 15 | 15 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 11 | 10 | 10 | 9 | 8 | 8 |
| Sell | 0 | 0 | 0 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29 | 29 | 29 | 29 | 28 | 28 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Reiterates $150 → $170 | Buy | Reiterates | $150 → $170 | +13.08% | Sep 4, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $155 | Buy | Maintains | $155 | +3.11% | Aug 31, 2026 |
| Argus Research | Argus Research | Buy Reiterates $145 → $170 | Buy | Reiterates | $145 → $170 | +13.08% | Aug 25, 2026 |
| Wolfe Research | Wolfe Research | Buy Maintains $155 → $180 | Buy | Maintains | $155 → $180 | +19.74% | Aug 25, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $150 | Hold | Maintains | $150 | -0.22% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
67.14B
from 65.01B
Increased by 3.27%
Revenue Next Year
70.30B
from 67.14B
Increased by 4.71%
EPS This Year
2.75
from 8.98
Decreased by -69.40%
EPS Next Year
9.55
from 2.75
Increased by 247.41%
EPS and Forward PE are based on non-GAAP adjusted numbers.